Axa
MDRX

Axa’s Veradigm Inc. Common Stock MDRX Stock Holding History

Axa’s Portfolio MDRX Stock Details MDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-333,590
Closed -$3.5M – 1132
2023
Q4 		$3.5M Sell
333,590
-106,635
-24% -$1.31M 0.01% 629
2023
Q3 		$5.78M Sell
440,225
-2,800
-0.6% -$36.7K 0.02% 502
2023
Q2 		$5.58M Sell
443,025
-113,516
-20% -$1.38M 0.02% 532
2023
Q1 		$7.26M Buy
556,541
+65,891
+13% +$1.07M 0.03% 476
2022
Q4 		$8.66M Buy
490,650
+162,800
+50% +$2.73M 0.03% 468
2022
Q3 		$4.99M Buy
327,850
+130,900
+66% +$2.12M 0.02% 576
2022
Q2 		$2.92M Sell
196,950
-127,050
-39% -$2.38M 0.01% 704
2022
Q1 		$7.3M Sell
324,000
-11,800
-4% -$239K 0.02% 551
2021
Q4 		$6.2M Sell
335,800
-37,000
-10% -$588K 0.02% 611
2021
Q3 		$4.98M Hold
372,800
– – 0.01% 680
2021
Q2 		$6.9M Sell
372,800
-121,800
-25% -$2.05M 0.02% 623
2021
Q1 		$7.43M Sell
494,600
-97,800
-17% -$1.57M 0.02% 592
2020
Q4 		$8.55M Sell
592,400
-11,000
-2% -$133K 0.03% 556
2020
Q3 		$4.91M Buy
603,400
+102,735
+21% +$839K 0.02% 628
2020
Q2 		$3.39M Buy
500,665
+225,465
+82% +$1.46M 0.01% 712
2020
Q1 		$1.94M Sell
275,200
-209,100
-43% -$1.7M 0.01% 744
2019
Q4 		$4.75M Sell
484,300
-1,500
-0.3% -$15.8K 0.02% 629
2019
Q3 		$5.33M Sell
485,800
-7,757
-2% -$79.6K 0.02% 632
2019
Q2 		$5.74M Sell
493,557
-96,243
-16% -$978K 0.02% 610
2019
Q1 		$5.63M Sell
589,800
-37,800
-6% -$418K 0.02% 617
2018
Q4 		$6.05M Sell
627,600
-28,700
-4% -$320K 0.03% 553
2018
Q3 		$9.35M Sell
656,300
-58,300
-8% -$792K 0.03% 499
2018
Q2 		$8.57M Buy
714,600
+32,300
+5% +$398K 0.03% 495
2018
Q1 		$8.43M Sell
682,300
-24,000
-3% -$341K 0.03% 506
2017
Q4 		$10.3M Buy
706,300
+364,444
+107% +$5.06M 0.04% 463
2017
Q3 		$4.87M Buy
+341,856
New +$4.42M 0.02% 630
2017
Q1 		– Sell
-429,600
Closed -$4.39M – 1331
2016
Q4 		$4.39M Buy
429,600
+1,500
+0.4% +$17.1K 0.02% 608
2016
Q3 		$5.64M Sell
428,100
-13,000
-3% -$174K 0.02% 541
2016
Q2 		$5.6M Buy
441,100
+31,400
+8% +$416K 0.03% 542
2016
Q1 		$5.41M Buy
409,700
+271,500
+196% +$3.56M 0.02% 544
2015
Q4 		$2.13M Buy
+138,200
New +$1.98M 0.01% 757

Other funds holding MDRX

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Axa's MDRX Position: Q1 2024 in Review

Axa sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 333,590 shares — an estimated $3.5M sold.

Axa first reported a position in MDRX in Q4 2015 and held it in 31 quarters. The position peaked at $10.3M in Q4 2017. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

  • Axa reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Axa sold 333,590 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $3.5M.
  • Axa first reported a position in Veradigm Inc. Common Stock in Q4 2015 and held it in 31 quarters.
  • Axa's Veradigm Inc. Common Stock position peaked at $10.3M in Q4 2017.
  • 35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on Axa's 13F filing for Q1 2024, filed 15 May 2024.